$IDXX News

Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?

Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding

IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve

Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?

IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution

IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests

IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day - Slideshow

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710

IDEXX Laboratories: Worth The Premium

Here is Why Growth Investors Should Buy Idexx (IDXX) Now

UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary

IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...

IDEXX Laboratories Q2 Earnings Call Highlights

IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-Market